CoChat

Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain

Muzii, Ludovico, Galati, Giulia, Di Tucci, Chiara, Di Feliciantonio, Mara, Perniola, Giorgia, Di Donato, Violante, Benedetti Panici, Pierluigi, Vignali, Michele · 2020 · Gynecological Endocrinology

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

The aim of the present study was to evaluate the effect of medical treatment of ovarian endometriomas on cyst diameter, associated pain, and ovarian reserve as measured with antral follicle count (AFC) and anti-Mullerian hormone (AMH). In this prospective study, 32 patients with unilateral endometrioma associated with pelvic pain, underwent 6-month medical treatment with dienogest. Before treatment, and at the end of 6 months of treatment, patients underwent evaluation of endometrioma diameter and AFC at transvaginal ultrasonography, measurement of AMH, and evaluation of associated pain. Mean cyst diameter was 4.0 ± 1.3 cm at baseline, and 2.4 ± 1.2 cm after 6 months of treatment (p < .0001), for a reduction in diameter of 40% and a reduction in volume of 79%. Mean visual analog scale score at enrollment was 6.3 ± 2.0, with a significant improvement at 6 months (0.9 ± 1.0, p < .0001). AFC for the affected ovary improved from 4.2 ± 2.8 at baseline, to 8.6 ± 4.2 cm after 6 months (+105%; p < .0001). AMH did not change significantly from baseline (3.40 ± 2.32 ng/mL) to end of treatment (2.80 ± 1.90 ng/mL, –18%, p = .27). Medical treatment with dienogest significantly reduces endometrioma diameter and associated pain, whereas the ovarian reserve appears to be preserved, with a significant improvement of AFC and no significant change in AMH.

Overview

Integrity signals

Registry

Crossref · 10.1080/09513590.2019.1640199

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 17 references

Research works printed but not linked: 3

  1. Muzii L, 2017, Semin Reprod Med, 35, 25
  2. Hart RJ, 2008, Cochrane Database Syst Rev, 16, CD004992
  3. Ersahin AA, 2017, Eur Rev Med Pharmacol Sci, 21, 2499

Cited by

See all 55

Metadata

Authors
Muzii, L., Galati, G., Di Tucci, C., Di Feliciantonio, M., Perniola, G., Di Donato, V., Benedetti Panici, P., & Vignali, M.
Affiliations
  • Sapienza University of Rome (IT)
  • Department of Obstetrics and Gynecology, “Sapienza” University of Rome, Rome, Italy;
  • University of Milan (IT)
Corresponding author
Muzii, Ludovico
Venue
Gynecological Endocrinology
Published
2019-07-14
Volume
36
Issue
1
Pages
81-83
ISSN
  • 0951-3590 (ISSN-L)
  • 1473-0766
OpenAlex
W2959862727
Cited by
55
References
17
Citations by year
2026: 7 · 2025: 4 · 2024: 14 · 2023: 10 · 2022: 7 · 2021: 10 · 2020: 3
FWCI
4.78
Type
journal article
Language
en
Open access
closed
Locations
  • Gynecological Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
endometrioma, dienogest, medical treatment, ovarian reserve, antral follicle count, anti-Müllerian hormone, cyst diameter, pelvic pain, GnRH agonist
MeSH terms
Adult, Endometriosis, Female, Ovarian Follicle, Hormone Antagonists, Humans, Nandrolone, Ovarian Diseases, Pain Measurement, Ultrasonography, Treatment Outcome, Pelvic Pain, Anti-Mullerian Hormone, Ovarian Reserve

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain. https://app.cochat.ai/papers/10.1080/09513590.2019.1640199
The paper
Muzii, L., Galati, G., Di Tucci, C., Di Feliciantonio, M., Perniola, G., Di Donato, V., Benedetti Panici, P., & Vignali, M. (2020). Medical treatment of ovarian endometriomas: a prospective evaluation of the effect of dienogest on ovarian reserve, cyst diameter, and associated pain. Gynecological Endocrinology. https://doi.org/10.1080/09513590.2019.1640199

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.